☆ 4.6 Article

Covalent Inhibitors from Saudi Medicinal Plants Target RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2

VIRUSES-BASEL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors

Shenghua Gao et al.

Summary: DF-47 and DF-51 were identified as effective inhibitors of SARS-CoV-2/DENV polymerase through RdRp inhibition screening and in vitro antiviral study. In silico simulation revealed stable binding modes between DF-47/DF-51 and SARS-CoV-2/DENV RdRp, including chelating with Mg2+ near the polymerase active site. These polyphenols have the potential to be developed into broad-spectrum, non-nucleoside RdRp inhibitors with a new scaffold.

MOLECULES (2023)

添加到收藏夹

Article Biology

Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular docking and deep learning methods

Alomgir Hossain et al.

Summary: Highly transmissive and rapidly evolving COVID-19, caused by SARS-CoV-2, has become a global pandemic and is extensively researched in academia. The main protease (Mpro) of SARS-CoV-2 has been identified as a potential therapeutic target for drug development. A phytochemical library consisting of 2431 compounds from 104 Korean medicinal plants was screened using molecular docking and deep learning, leading to the identification of two lead compounds, Catechin gallate and Quercetin 3-O-malonylglucoside, with inhibitory potency against Mpro.

COMPUTERS IN BIOLOGY AND MEDICINE (2023)

添加到收藏夹

Article Chemistry, Medicinal

Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)

Chamandi S. Dampalla et al.

Summary: The high morbidity and mortality of SARS-CoV-2 infection has greatly impacted global public health. Despite progress in vaccine development, the emergence of variants and breakthrough infections remain a major concern. There is a lack of small-molecule therapeutics and prophylactics to counter the spread of SARS-CoV-2 and other coronaviruses. This study focuses on the structure-guided design of potent inhibitors of SARS-CoV-2 3C-like protease, showing promising results in inhibiting viral replication.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Plant Sciences

Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches

Ya-Ni Zhang et al.

Summary: The study aims to discover new covalent inhibitors against SARS-CoV-2 3CLpro from herbal medicines. Ginkgo biloba extract 50 (GBE50) was found to effectively inhibit the activity of SARS-CoV-2 3CLpro, and the key constituents in GBE50 were identified. A total of 38 constituents and 26 peptides modified by 18 constituents were identified in GBE50. Gallocatechin and sciadopitysin showed the strongest inhibitory activity.

PHYTOMEDICINE (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation

Shahkaar Aziz et al.

Summary: In this study, existing and novel non-nucleoside inhibitors for SARS-CoV-2 RdRp were computationally screened from large chemical databases. These inhibitors showed strong binding affinity with RdRp, drug-like features, good absorption, distribution, metabolism, and excretion profile, and were found to be non-toxic. These findings hold promise for the discovery of novel drugs against COVID-19 in the future.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors

Nicoletta Brindani et al.

Summary: In this study, 17 new 1,4-benzopyrone derivatives were designed, synthesized, and characterized for their ability to inhibit the RdRp enzyme. Compounds 4, 5, and 8 showed promising activity in inhibiting RdRp with improved pharmacokinetics compared to initial hits and no cytotoxicity effects on normal cells (HEK-293). Compound 8 (ARN25592) was identified as the most promising inhibitor.

BIOORGANIC & MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Review Chemistry, Medicinal

Recent Advances in Covalent Drug Discovery

Daniel Schaefer et al.

Summary: Despite the increasing number of biologics license applications, the development of covalent inhibitors remains a growing field in drug discovery. The successful approval of certain covalent protein kinase inhibitors and the recent discovery of covalent inhibitors for viral proteases represent advancements in covalent drug development. Covalent bonds targeting proteins offer advantages in target selectivity, drug resistance, and administration concentration. The electrophile (warhead) is a crucial factor for covalent inhibitors, dictating selectivity and reactivity, and can be modified through rational designs. Covalent inhibitors are also finding applications in protein degradation and targeting chimeras (PROTACs) for 'undruggable' proteins, as well as in the treatment of SARS-CoV-2.

PHARMACEUTICALS (2023)

添加到收藏夹

Article Biology

SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations

Roman S. Tumskiy et al.

Summary: The aim of this study was to design, characterize, and select potential dual inhibitors against the essential viral proteins Mpro and PLpro in order to develop new drugs against COVID-19. Computational methods were used to generate new compounds with drug-like properties and low toxicity, and molecular dynamics simulations confirmed their stability in complex with the target proteases.

COMPUTERS IN BIOLOGY AND MEDICINE (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Protease inhibitors from Theobroma cacao impair SARS-CoV-2 replication in vitro

Brenda Conceica Guimaraes Santana et al.

Summary: SARS-CoV-2, a newly emerging virus from the Coronaviridae family, has infected over 700 million people worldwide and caused over 6 million deaths. Through protein-protein molecular docking, two cystatins from Theobroma cacao were found to inhibit the replication of SARS-CoV-2 without toxicity to host cells. Further studies are needed to explore the action mechanisms of these protease inhibitors in controlling SARS-CoV-2 replication in human cells.

HELIYON (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor

Shalini Mathpal et al.

Summary: This research aims to identify new drug candidates for the inhibition of the Main protease enzyme of COVID-19 using in silico techniques. By performing molecular docking and molecular dynamics simulation, four potential drugs were discovered among 3180 FDA-approved drugs. These findings provide important leads for the development of novel drugs against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

添加到收藏夹

Article Immunology

Outpatient Therapies for COVID-19: How Do We Choose?

Todd C Lee et al.

Open Forum Infectious Diseases (2022)

添加到收藏夹

Article

RNA-DEPENDENT RNA POLYMERASE (RDRP) INHIBITOR DRUGS AGAINST SARS-COV-2: A MOLECULAR DOCKING STUDY

Sarah GADO et al.

Ankara Universitesi Eczacilik Fakultesi Dergisi (2022)

添加到收藏夹

Article Biology

Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19

Arpana Parihar et al.

Summary: In this study, plant-based phytochemicals were screened for their therapeutic potential against SARS-CoV-2 using computational tools. The results identified isoskimmiwallin and terflavin A as potential inhibitors of RdRp, and isoquercitrin and isoorientin as lead molecules against Mpro. These findings could contribute to the development of novel therapeutics for COVID-19.

COMPUTERS IN BIOLOGY AND MEDICINE (2022)

添加到收藏夹

Article Chemistry, Medicinal

Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening

Li-chuan Zhang et al.

Summary: In this study, three compounds were identified that have the potential to inhibit the main protease and papain-like protease of SARS-CoV-2. These compounds can be further investigated as potential lead compounds for SARS-CoV-2 inhibitors.

FUTURE MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Immunology

Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2

B. Uma Reddy et al.

Summary: This review provides an overview of the potential anti-SARS-CoV-2 activities of plants and their bioactive compounds, highlighting their roles in inhibiting viral infection, as well as their anti-inflammatory and antioxidant properties. It also discusses plant-based therapies in various stages of clinical trials.

MICROBIAL PATHOGENESIS (2022)

添加到收藏夹

Review Microbiology

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

Gary McLean et al.

Summary: The emergence of new variants of SARS-CoV-2 has raised concerns about the impact on vaccination programs. Current vaccines are effective against some variants, but effectiveness varies. Booster programs can restore protection against infection and symptomatic disease, but the effectiveness may decrease over time. Antibodies may have reduced neutralizing activity against certain variants, but T-cell responses remain relatively stable.

MBIO (2022)

添加到收藏夹

Review Immunology

Molnupiravir and Its Antiviral Activity Against COVID-19

Lili Tian et al.

Summary: Molnupiravir is a broad-spectrum antiviral drug with the potential to treat and prevent various coronaviruses, including SARS-CoV-2. Clinical trials have shown its beneficial effects and favorable safety profile for mild to moderate COVID-19 patients. Molnupiravir has the potential to be a therapeutic candidate against COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Chemistry, Medicinal

When Virtual Screening Yields Inactive Drugs: Dealing with False Theoretical Friends

Jose P. Ceron-Carrasco

Summary: The search for antivirals against SARS-CoV-2 began as soon as the WHO declared the coronavirus outbreak a pandemic. Experimental and theoretical approaches have been used to identify potential antiviral compounds. Remdesivir has been identified as the standard treatment for severe cases, while other oral alternatives have also been proposed. However, the use of virtual screening simulations may not be the best strategy for identifying new antivirals, and a combination of theory and biological assays is needed for drug repurposing.

CHEMMEDCHEM (2022)

添加到收藏夹

Article Infectious Diseases

The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion

Ting-Hsu Chen et al.

Journal of Infection and Public Health (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Repurposing antiviral phytochemicals from the leaf extracts of Spondias mombin (Linn) towards the identification of potential SARSCOV-2 inhibitors

Akwasi Boadu et al.

Summary: This study investigated the potential use of phytochemical compounds from Spondias mombin L as inhibitors of the SARS-CoV-2 virus. The compounds Geraniin and 2-O-Caffeoyl-(+)-allohydroxycitric acid showed potential as inhibitors, targeting key proteins of the virus. However, further in vitro and in vivo evaluation is needed to confirm their effectiveness as therapeutic candidates for SARS-CoV-2.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Microbiology

Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase

Kittirat Glab-ampai et al.

Summary: This study tested the effectiveness of a cell-penetrating human single-chain antibody variable fragment (superantibody) against emerging/reemerging RNA viruses. The superantibody was found to inhibit the replication of multiple RNA viruses by disrupting the catalytic activity of the viral polymerase. These findings suggest that the superantibody has potential as a broadly effective non-chemical therapeutic agent against positive sense-RNA viruses.

FRONTIERS IN MICROBIOLOGY (2022)

添加到收藏夹

Article Biology

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro

Muhammad Hassam et al.

Summary: The worldwide pandemic of COVID-19 and its variants have posed a serious threat to human civilization. In the search for COVID-19 treatments, researchers have used computational methods to identify four potential compounds that target the Mpro protein and may aid in the recovery from infection.

COMPUTERS IN BIOLOGY AND MEDICINE (2022)

添加到收藏夹

Article Immunology

Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies

Muhammad Azeem et al.

Summary: This study identified potential phytochemicals with antiviral potential against SARS-CoV-2 through virtual screening, and found that these compounds exhibited good thermal stability and stable binding affinity with key viral proteins.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure-Activity Relationship Insights and Evolution Perspectives

Gabriele La Monica et al.

Summary: This perspective analyzes the current research status of covalent SARS-CoV-2 MPRO inhibitors, including different categories of drugs, their mechanisms, and the roles of pharmacophoric moieties and chiral carbons. The provided analyses of noncovalent and covalent in vitro protocols are helpful for the scientific community to discover more efficient inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

The Remarkable Selectivity of Nirmatrelvir

Damien Y. Duveau et al.

Summary: The SARS-CoV-2 main protease is an important target for therapeutic interventions against COVID-19. The first approved inhibitor, Nirmatrelvir, shows activity against cysteine proteases and has significant therapeutic implications.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation

Adnane Aouidate et al.

Summary: The new SARS-CoV-2 coronavirus has caused the COVID-19 pandemic, with no effective treatments or vaccines available currently. Computational methods have been used to identify potential virus inhibitors, leading to the discovery of three promising compounds for fighting COVID-19. Molecular dynamics simulations showed that these compounds remained stable and may be suitable candidates for further experimental analysis.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

添加到收藏夹

Article Plant Sciences

Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication

Suresh Kumar et al.

Summary: This study aimed to investigate the binding potential of phytochemicals with coronavirus protein Nsp15, demonstrating approximately 50 phytochemicals capable of inhibiting viral replication. Further in vitro and in vivo tests are needed for confirmation of these findings.

PHYTOMEDICINE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Crystal structure of SARS-CoV-2 papain-like protease

Xiaopan Gao et al.

Summary: This study provided structural frameworks for PLpro inhibitor design targeting SARS-CoV-2, showing that existing SARS-CoV PLpro inhibitors have some efficacy against SARS-CoV-2 and explored the inhibition mechanism of GRL0617.

ACTA PHARMACEUTICA SINICA B (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Recent progress in covalent warheads for in vivo targeting of endogenous proteins

Naoya Shindo et al.

Summary: Covalent drugs modify endogenous target proteins to exert potent and durable activity, with current focus on developing targeted covalent inhibitors (TCIs) to maximize efficacy and minimize toxicity risks. The characteristics of warheads affect the target selectivity of TCIs.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19

Gourab Das et al.

Summary: Using artificial intelligence and molecular docking simulations, a set of 9 ligand molecules have been identified that target the envelope (E) protein of SARS-CoV-2. These substances offer potential for further research into their mechanisms of action related to various symptoms in infected patients.

GENOMICS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase

Fabian Bylehn et al.

Summary: This study examined the molecular interactions of Remdesivir, ribavirin, and favilavir, revealing that they all bind strongly at the active site but may act via slightly different mechanisms. Remdesivir showed similar binding interactions to the natural base adenine, suggesting a potential secondary mechanism where it destabilizes the protein complex and interactions with RNA strands.

ACS CENTRAL SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance

Aditya K. Padhi et al.

Summary: With the use of mutational mapping, it was predicted that only a few mutations in the nsp12 subunit of RdRp are needed for SARS-CoV-2 to develop resistance to remdesivir. Certain mutations resulted in decreased binding affinity to remdesivir, indicating drug resistance. Identifying potential hotspot residues prone to mutation improves our understanding of SARS-CoV-2 drug resistance and COVID-19 pathogenesis.

ISCIENCE (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?

Lucas Amaral-Machado et al.

Summary: The study aimed to review natural products as alternative methods for preventing ARDS, finding that PANPs have various anti-inflammatory pathways and promising potential as a treatment choice for preventing COVID-19-related ARDS.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Food Science & Technology

Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19-An in silico study

Shanmugaraj Gowrishankar et al.

Summary: This study utilized molecular docking analysis to explore the potential effects of three commonly used Indian herbs in combating COVID-19, and identified certain phytochemical constituents that demonstrated strong inhibitory properties. These components show promise for development into drugs for combating COVID-19.

FOOD AND CHEMICAL TOXICOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP

Katerina Naydenova et al.

Summary: The structure of the RNA polymerase inhibitor favipiravir bound to the SARS-CoV-2 RNA-dependent RNA polymerase has been determined, revealing its binding mode at the catalytic site. The inhibitor is weakly incorporated into the RNA primer strand, leading to suppression of RNA replication in the presence of natural nucleotides.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties

Sukanya Panikar et al.

Summary: This study evaluated the effect of bioactive compounds from Eucalyptus and Corymbia species essential oil on Mpro for potential COVID-19 treatment. Among the compounds studied, eucalyptol showed promising results as an effective therapy option with low toxicity. Further analysis is needed to explore its potential application in medicine.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Cell Biology

HLA-A*02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses

Pavlo A. Nesterenko et al.

Summary: Cross-reactivity and direct killing of target cells by SARS-CoV-2-specific CD8(+) T cells are not well studied. Isolating and overexpressing T cell receptors (TCRs) in allogeneic cells allows for extensive profiling of T cell reactivity. The discovery that some CD8(+) T cells can recognize multiple coronaviruses may help define vaccine epitopes that induce long-term immunity.

CELL REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2

Shruti Koulgi et al.

Summary: Drug repurposing studies targeting inhibition of RdRP of SARS-CoV-2 have shown the potential effect of small molecules. In this study, phytochemicals from Indian medicinal plants were found to have strong binding to RdRP, with cordifolide A and sitoindoside IX exhibiting high stability in binding.

PLOS ONE (2021)

添加到收藏夹

Article Crystallography

Virtual Screening and Molecular Docking Studies for Discovery of Potential RNA-Dependent RNA Polymerase Inhibitors

Mohammed Y. Ghazwani et al.

Summary: The current COVID-19 pandemic, caused by SARS-CoV-2, has affected over 111 million individuals globally, leading to health and economic challenges. Research has identified potential RdRp enzyme inhibitors that can be used for designing future antiviral drugs.

CRYSTALS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Tackling COVID-19 with neutralizing monoclonal antibodies

Davide Corti et al.

Summary: Monoclonal antibodies have revolutionized the treatment of several human diseases, including cancer, autoimmunity, and infectious diseases. Lessons learned from the COVID-19 pandemic have paved the way for the development of more monoclonal antibody-based therapeutics.

CELL (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2

Dhananjay Jade et al.

Summary: This study identified several compounds that inhibit SARS-CoV-2 proteases PLPRO and 3CLPRO through in silico virtual screening. These compounds demonstrated stability in molecular dynamics simulations and showed potential for treating COVID-19 infections.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

添加到收藏夹

Review Immunology

Neutralizing monoclonal antibodies for treatment of COVID-19

Peter C. Taylor et al.

Summary: The study discusses the clinical utility of neutralizing monoclonal antibody therapies targeting SARS-CoV-2, emphasizing the importance of patient stratification, biomarkers, risk factors, and other clinical considerations.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Ligand Conformational Bias Drives Enantioselective Modification of a Surface-Exposed Lysine on Hsp90

Adolfo Cuesta et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons

Shivraj Hariram Nile et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Calvin J. Gordon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Yan Gao et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Wanchao Yin et al.

SCIENCE (2020)

添加到收藏夹

Article Biology

Drug treatment options for the 2019-new coronavirus (2019-nCoV)

Hongzhou Lu

BIOSCIENCE TRENDS (2020)

添加到收藏夹

Article Infectious Diseases

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

Qifang Bi et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Molecular immune pathogenesis and diagnosis of COVID-19

Xiaowei Li et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Coronavirus membrane fusion mechanism offers a potential target for antiviral development

Tiffany Tang et al.

ANTIVIRAL RESEARCH (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synthesis, Docking, Computational Studies, and Antimicrobial Evaluations of New Dipeptide Derivatives Based on Nicotinoylglycylglycine Hydrazide

Hemat S. Khalaf et al.

MOLECULES (2020)

添加到收藏夹

Review Virology

Natural product-derived phytochemicals as potential agents against coronaviruses: A review

Janice S. Mani et al.

VIRUS RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Alina Shitrit et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study

Jamshaid Ahmad et al.

HELIYON (2020)

添加到收藏夹

Letter Rheumatology

Preventing COVID-19-induced pneumonia with anticytokine therapy

Giovanni Monteleone et al.

LANCET RHEUMATOLOGY (2020)

添加到收藏夹

Article Toxicology

Mechanisms of synergistic neurotoxicity induced by two high risk pesticide residues - Chlorpyrifos and Carbofuran via oxidative stress

Dong-Jun Fu et al.

TOXICOLOGY IN VITRO (2019)

添加到收藏夹

Article Chemistry, Medicinal

Comparative Evaluation of Covalent Docking Tools

Andrea Scarpino et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Structural flexibility and protein adaptation to temperature: Molecular dynamics analysis of malate dehydrogenases of marine molluscs

Yun-wei Dong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹

Article Plant Sciences

Cytotoxic and antiinflammatory activities of the chemical constituents isolated from Baccharoides schimperi DC

S. Ahmed et al.

SOUTH AFRICAN JOURNAL OF BOTANY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit

Takeshi Noshi et al.

ANTIVIRAL RESEARCH (2018)

添加到收藏夹

Article Biochemical Research Methods

A Perspective on the Kinetics of Covalent and Irreversible Inhibition

John M. Strelow

SLAS DISCOVERY (2017)

添加到收藏夹

Article Plant Sciences

Chemical constituents from Oncocalyx glabratus and their biological activities

Sarfaraz Ahmed et al.

PHYTOCHEMISTRY LETTERS (2017)

添加到收藏夹

Review Multidisciplinary Sciences

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Yousuke Furuta et al.

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

ACTIVITY GUIDED ISOLATION OF CHEMICAL CONSTITUENTS FROM THE BIOLOGICALLY ACTIVE METHANOL EXTRACT OF EUPHORBIA SCHIMPERI C. PRESL

Sarfaraz Ahmed et al.

BULLETIN OF THE CHEMICAL SOCIETY OF ETHIOPIA (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural features determining thermal adaptation of esterases

Filip Kovacic et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2016)

添加到收藏夹

Review Microbiology

Approved Antiviral Drugs over the Past 50 Years

Erik De Clercq et al.

CLINICAL MICROBIOLOGY REVIEWS (2016)

添加到收藏夹

Article Chemistry, Physical

CHARMM TIP3P Water Model Suppresses Peptide Folding by Solvating the Unfolded State

Sander Boonstra et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2016)

添加到收藏夹

Article Microbiology

Potency and Resistance Analysis of Hepatitis C Virus NS5B Polymerase Inhibitor BMS-791325 on All Major Genotypes

Mengping Liu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

添加到收藏夹

Review Cell Biology

RNA synthetic mechanisms employed by diverse families of RNA viruses

Sarah M. McDonald

WILEY INTERDISCIPLINARY REVIEWS-RNA (2013)

添加到收藏夹

Article Chemistry, Multidisciplinary

Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations

Wenbo Yu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Variability in docking success rates due to dataset preparation

Christopher R. Corbeil et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)

添加到收藏夹

Article Chemistry, Multidisciplinary

CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields

K. Vanommeslaeghe et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures

Paul Labute

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)

添加到收藏夹

Article Chemistry, Multidisciplinary

Software news and updates - CHARNIM-GUI: A web-based grraphical user interface for CHARMM

Sunhwan Jo et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)

添加到收藏夹

Article Pharmacology & Pharmacy

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

Tin-Yun Ho et al.

ANTIVIRAL RESEARCH (2007)

添加到收藏夹

Article Chemistry, Medicinal

Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space

Marwen Naim et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)

添加到收藏夹

Review Virology

Mechanisms of action of ribavirin against distinct viruses

JD Graci et al.

REVIEWS IN MEDICAL VIROLOGY (2006)

添加到收藏夹

Review Chemistry, Multidisciplinary

Scalable molecular dynamics with NAMD

JC Phillips et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

添加到收藏夹

Article Microbiology

Mechanism of action of T-705 against influenza virus

Y Furuta et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

添加到收藏夹

Article Chemistry, Physical

Generalized born model: Analysis, refinement, and applications to proteins

M Wojciechowski et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.